SITAGLIPTIN PHOSPHATE 50mg. IP + METFORMIN 500mg. IP

An antihyperglycemic drug that reduces high blood glucose levels in patients with type 2 diabetes. An effective treatment for type 2 diabetes mellitus that assists patients to achieve glycemic control. (Elizabeth M Migoya, 2010) A well-tolerated, efficacious, weight-neutral antidiabetic agent, with a low incidence of hypoglycemia. (Sreevidya Subbarayan, 2011) A valuable drug for type 2 diabetes patients who are not adequately controlled by taking either sitagliptin or metformin alone. (Jonathan Kent Reynolds, 2008) A safe and effective for lowering glucose levels and minimizing the pill burden in patients with type-2 diabetes. (Erin L. St. Onge, 2012) Improves glycemic control by reducing both fasting and postprandial glucose concentrations. (Deacon, 2007) Significantly more effective on glycated hemoglobin levels than either drug used alone in type 2 diabetes subjects. (2008) Provides effective fasting and postprandial glycemic control in a wide range of patients with type 2 diabetes. (Avraham Karasik, 2008) Offers superior glycemic improvement than metformin monotherapy in patients with type 2 diabetes. (C Reasner, 2011)